GSBD:NYSEGoldman Sachs BDC, Inc. Analysis
Data as of 2026-04-07 - not real-time
$9.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Goldman Sachs BDC trades at a forward P/E of 8.98 versus an industry average of 16.68, and a price‑to‑book of 0.73, indicating a clear valuation discount. However, the company’s revenue has contracted 17% year‑over‑year and operating margins, while strong dividend yield of 15.84% is backed by a payout ratio above 100%, raising sustainability concerns. Technical metrics reinforce a cautious outlook: the 20‑day SMA (9.11) sits below the 50‑day SMA (9.21), the 200‑day SMA (10.19) is well above current price, RSI is neutral at 53.8, and MACD is bearish with a negative histogram. Volume trends are decreasing, and the stock is in a bearish trend direction, with support near $8.66 and resistance at $9.43. Recent material news includes a $400 million 5.65% note issuance maturing in 2030, providing additional liquidity, and integration into Goldman Sachs’ Direct Lending platform that has improved portfolio quality. These factors suggest the stock is undervalued on a value basis but faces short‑term pressure from earnings momentum and dividend sustainability. Investors should weigh the discount against the risk of continued revenue decline and potential dividend adjustments.
Given the mixed signals, a nuanced approach is warranted: the valuation gap and asset‑backed business model support a longer‑term value case, while the bearish technicals and high payout ratio advise caution in the near term.
Given the mixed signals, a nuanced approach is warranted: the valuation gap and asset‑backed business model support a longer‑term value case, while the bearish technicals and high payout ratio advise caution in the near term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and SMA crossover
- Decreasing volume and bearish trend direction
- High dividend payout ratio above 100%
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation discount relative to industry peers
- Improved portfolio quality from Direct Lending integration
- Revenue contraction still present
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong asset‑backed balance sheet with low beta
- Undervalued price-to-earnings and price-to-book multiples
- Potential dividend adjustment improving sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-17.10%
Profit Margin32.63%
P/E Ratio9.0
ROE7.96%
ROA5.32%
Debt/Equity131.97
P/B Ratio0.7
Op. Cash Flow$325.7M
Free Cash Flow$108.7M
Industry P/E16.7
Technical Analysis
TrendBearish
RSI53.8
Support$8.66
Resistance$9.43
MA 20$9.11
MA 50$9.21
MA 200$10.19
MACDBearish
VolumeDecreasing
Fear & Greed Index76.63
Valuation
Target Price$9.13
Upside/Downside-1.35%
GradeUndervalued
TypeValue
Dividend Yield15.84%
Risk Assessment
Beta0.57
Volatility22.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.